2 results
Approved WMOCompleted
To determine whether treatment with RAD001 10 mg/d plus Sandostatin LARĀ® prolongs the progression free survival (PFS) compared to treatment with Sandostatin LARĀ® alone in patients with advanced carcinoid tumor.
Approved WMOWill not start
To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 2 dose strengths of Bimatoprost SR in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) after initial and repeated administrations